Abbott Laboratories (Pakistan) (KAR:ABOT) Cash Flow for Dividends: ₨-969 Mil (TTM As of Mar. 2026)


KAR:ABOT Abbott Laboratories (Pakistan) Ltd KAR:ABOT
77 GF Score
Price ₨966.44
GF Value ₨1,001.38
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Abbott Laboratories (Pakistan) Cash Flow for Dividends?

Abbott Laboratories (Pakistan) KAR:ABOT 77 Cash Flow for Dividends is ₨-969 Mil as of Mar. 2026. GuruFocus rates KAR:ABOT with a GF Score™ of 77/100 and a GF Value™ of ₨1,001.38 (Fairly Valued). The stock has 2 warning signs investors should review.

Abbott Laboratories (Pakistan)'s cash flow for dividends for the three months ended in Mar. 2026 was ₨-0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₨-969 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Abbott Laboratories (Pakistan)'s quarterly payment of dividends increased from Sep. 2025 (₨-1 Mil) to Dec. 2025 (₨-210 Mil) but then declined from Dec. 2025 (₨-210 Mil) to Mar. 2026 (₨-0 Mil).

Abbott Laboratories (Pakistan)'s annual payment of dividends declined from Dec. 2023 (₨-1,374 Mil) to Dec. 2024 (₨-1,030 Mil) and declined from Dec. 2024 (₨-1,030 Mil) to Dec. 2025 (₨-972 Mil).

Abbott Laboratories (Pakistan) Cash Flow for Dividends Related Terms

Abbott Laboratories (Pakistan) Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories (Pakistan)'s Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories (Pakistan) Cash Flow for Dividends Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,397.64 -1,016.08 -1,374.41 -1,030.46 -971.56

Abbott Laboratories (Pakistan) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.42 -758.13 -0.86 -210.16 -0.08
KAR:ABOT
77GF Score
Abbott Laboratories (Pakistan) Ltd KAR:ABOT
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories (Pakistan) Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨-969 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₨-969 Mil mean?
Abbott Laboratories (Pakistan) (KAR:ABOT) has a Cash Flow for Dividends of ₨-969 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Abbott Laboratories (Pakistan) and its competitors.
Is Abbott Laboratories (Pakistan)'s Cash Flow for Dividends too high?
Abbott Laboratories (Pakistan)'s current Cash Flow for Dividends is ₨-969 Mil. Overall, Abbott Laboratories (Pakistan) has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories (Pakistan)'s Cash Flow for Dividends compare to ZTS and UTHR?
Abbott Laboratories (Pakistan)'s Cash Flow for Dividends of ₨-969 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Abbott Laboratories (Pakistan) and its competitors. Abbott Laboratories (Pakistan)'s current Cash Flow for Dividends is ₨-969 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories (Pakistan) stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) (KAR:ABOT) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,001.38, compared to a current price of ₨966.44 — trading 3.5% below its estimated fair value. The current Cash Flow for Dividends is ₨-969 Mil. Abbott Laboratories (Pakistan)'s overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Abbott Laboratories (Pakistan) (KAR:ABOT), the current Cash Flow for Dividends is ₨-969 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (Pakistan) (KAR:ABOT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) stock appears to be undervalued. The current stock price of ₨966.44 is trading 3.5% below its estimated GF Value™ of ₨1,001.38. GuruFocus considers Abbott Laboratories (Pakistan) to be Fairly Valued.

Key valuation signals for KAR:ABOT:

  • Cash Flow for Dividends: ₨-969 Mil
  • GF Value™: ₨1,001.38 vs. price of ₨966.44 (3.5% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the KAR:ABOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories (Pakistan) Business Description

Address Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. The company's Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
77GF Score

Get the complete analysis for KAR:ABOT

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨966.44
Price
₨1,001.38
GF Value